RG-001 (Rigerna)

N/A

Report date: 2025/06/26 17:37:33
NME

Base Information

Drug NameRG-001 (Rigerna)
Drug Alias NameRG-001RG-001 (Rigerna)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionApolipoprotein(a) modulators
TargetsApolipoprotein(a)
Therapy Area/IndicationsHyperlipidemiasCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Xuanjing Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Xuanjing Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A